Skip to main content

Table 1 Demographic, clinical, and laboratory findings of each group

From: Magnesium-permeable TRPM6 polymorphisms in patients with meningomyelocele

 

Study group

Control group

Age (years)

3.1 ± 3.22

9.7 ± 2.21

Female/male

60/90

75/75

History of another baby with MMC in the family

18 (11.9 %)

Consanguinity between parents

41 (27.3 %)

15 (10 %)

History of another baby with a congenital anomaly in the family

32 (21.3 %)

10 (6.6 %)

Drug use during pregnancy

25 (16.6 %)

15 (10 %)

Calcium (mg/dL)

9.09 ± 1.24

10.0 ± 1.25

Mg2+ (mg/dL)

1.98 ± 0.62

2.3 ± 0.39

  1. MMC Meningomyelocele